奥本海默：维持Alumis评级

证券之星2025-05-16

奥本海默：维持Alumis(ALMS.US)评级，由优于大市调整至优于大市评级,目标价由26.00美元调整至25.00美元。Alumis(ALMS.US)公司简介：Alumis Inc是一家临床阶段的生物制药公司，专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。该公司利用其专有的精确数据分析平台、生物学见解、以及在精准医学药物发现、开发和免疫学方面拥有丰富经验的专家团队，通过用靶向...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535749708?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-16 02:21","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535749708","market":"us","top_or_hot":-1,"title":"奥本海默：维持Alumis评级","media":"证券之星","content":"<div>\n<p>奥本海默：维持Alumis(ALMS.US)评级，由优于大市调整至优于大市评级,目标价由26.00美元调整至25.00美元。Alumis(ALMS.US)公司简介：Alumis Inc是一家临床阶段的生物制药公司，专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。该公司利用其专有的精确数据分析平台、生物学见解、以及在精准医学药物发现、开发和免疫学方面拥有丰富经验的专家团队，通过用靶向...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516022512a6e0aaec&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>奥本海默：维持Alumis评级</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n奥本海默：维持Alumis评级\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-16 02:21 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516022512a6e0aaec&s=b><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>奥本海默：维持Alumis(ALMS.US)评级，由优于大市调整至优于大市评级,目标价由26.00美元调整至25.00美元。Alumis(ALMS.US)公司简介：Alumis Inc是一家临床阶段的生物制药公司，专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。该公司利用其专有的精确数据分析平台、生物学见解、以及在精准医学药物发现、开发和免疫学方面拥有丰富经验的专家团队，通过用靶向...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516022512a6e0aaec&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALMS","symbol_name":"Alumis Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516022512a6e0aaec&s=b","article_id":"2535749708","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516022512a6e0aaec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535749708","pubTimestamp":1747333286,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"奥本海默：维持Alumis(ALMS.US)评级，由优于大市调整至优于大市评级,目标价由26.00美元调整至25.00美元。Alumis(ALMS.US)公司简介：Alumis Inc是一家临床阶段的生物制药公司，专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。该公司利用其专有的精确数据分析平台、生物学见解、以及在精准医学药物发现、开发和免疫学方面拥有丰富经验的专家团队，通过用靶向疗法取代广泛的免疫抑制来创造显著改善患者生活的药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["rate"],"viewcount":null,"language":"zh","relate_stocks":{"ALMS":"Alumis Inc."},"translate_title":"Oppenheimer: Keep Alumis Rating","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALMS":1},"content_text":"奥本海默：维持Alumis(ALMS.US)评级，由优于大市调整至优于大市评级,目标价由26.00美元调整至25.00美元。Alumis(ALMS.US)公司简介：Alumis Inc是一家临床阶段的生物制药公司，专注于识别、收购和加速自身免疫性疾病变革性药物的开发和商业化。该公司利用其专有的精确数据分析平台、生物学见解、以及在精准医学药物发现、开发和免疫学方面拥有丰富经验的专家团队，通过用靶向疗法取代广泛的免疫抑制来创造显著改善患者生活的药物。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535749708","isCrawlerRequest":true}